Evidence map›Paper›PMID 42101743›Full record

ArticleGeroScience2026

Age- and cognitive load-related variability and entropy of gait: integrating coefficient of variation, median absolute deviation, and permutation entropy of spatiotemporal parameters into the Semmelweis Study gait assessment framework.

Peter Mukli, Mihaly Muranyi, Ágnes Lipecz, Zsofia Szarvas, Tamás Csípő, Mónika Fekete, Vince Fazekas-Pongor, Anna Peterfi, Ágnes Fehér, Norbert Dosa and 24 more

Abstract read
In one paragraph

Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Peter Mukli *Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Mihaly Muranyi *Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Ágnes Lipecz *Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Zsofia SzarvasVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Tamás CsípőInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Mónika FeketeInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Vince Fazekas-PongorInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Anna PeterfiInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Ágnes FehérInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Norbert DosaVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Csilla KaposváriInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Anna AliquanderInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Wei Yi HungInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Dávid MajorInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Zalan KaposztaVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Attila MatiscsákFaculty of Health Sciences, Semmelweis University, Budapest, Hungary.
Gabriella DörnyeiFaculty of Health Sciences, Semmelweis University, Budapest, Hungary.
Zoltan BenyoInstitute of Translational Medicine, Semmelweis University, 1094, Budapest, Hungary.
Roland PataiVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Boglarka CsíkInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Rafal GulejVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Anna UngvariInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Panna T PónyaiInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Emese GyőrffyInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Attila KállaiInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Márton SándorInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Peter VargaInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Adam G TabakInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Stefano TarantiniVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Róza ÁdányInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Béla MerkelyHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Anna CsiszarVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Andriy YabluchanskiyVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Zoltan UngvariVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Zoltan-Ungvari@ou.edu.ORCID http://orcid.org/0000-0002-6035-6039

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging profoundly alters the neuromotor and cognitive systems that support gait control, leading to increased variability and instability that predict functional decline and dementia risk. In this pilot study, conducted to inform the design of the Semmelweis Study gait assessment pipeline, we examined how aging and cognitive load influence the magnitude and temporal organization of gait fluctuations. The Semmelweis Study is a large, prospective workplace cohort at Semmelweis University designed to identify the determinants of unhealthy aging and the mechanisms that preserve functional resilience across the life course. One hundred three adults aged 23-87 years completed single- and dual-task walking trials on a 20-foot pressure-sensitive walkway. Gait variability was quantified using the median absolute deviation (MAD) and coefficient of variation (CoV) of key spatiotemporal parameters, while permutation entropy (PE) captured the complexity of stride-to-stride dynamics. Aging was associated with progressive increases in both the variability (MAD, CoV) and changes in orderliness (PE) of gait fluctuations, particularly under dual-task conditions, suggesting a dual contribution of neuromotor degradation and compensatory recruitment of higher-order control processes. The amplification of these effects during cognitive load highlights the vulnerability of cognitive-motor integration with advancing age. By integrating robust, relative, and nonlinear variability metrics within a unified analytical framework, this study provides a multidimensional characterization of gait control and establishes sensitive indicators for detecting early functional decline. Within the translational framework of the Semmelweis Study, these quantitative gait measures-together with vascular, metabolic, and cognitive assessments-are expected to serve as informative components of a comprehensive biomarker system aimed at identifying early determinants of unhealthy brain aging and guiding preventive strategies to promote healthy longevity.

Indexed as

AgingCognitionGaitAdultAgedAged, 80 and overDual-Task TestsEntropyFemaleGait AnalysisHumansMaleMiddle AgedPilot ProjectsProspective StudiesYoung AdultAgingCerebrovascular agingCoefficient of variationCognitive–motor integrationDual-task walkingGait variabilityHealthy longevityMedian absolute deviationPermutation entropySemmelweis Study

Identifiers

PMID42101743
PMCPMC13356253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.